Your browser doesn't support javascript.
loading
2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders.
Solnica, Bogdan; Sygitowicz, Grazyna; Sitkiewicz, Dariusz; Józwiak, Jacek; Kasperczyk, Slawomir; Broncel, Marlena; Wolska, Anna; Odrowaz-Sypniewska, Grazyna; Banach, Maciej.
Afiliación
  • Solnica B; Polish Society for Laboratory Diagnostics.
  • Sygitowicz G; Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.
  • Sitkiewicz D; Polish Society for Laboratory Diagnostics.
  • Józwiak J; Department of Clinical Chemistry and Laboratory Diagnostics, Medical University of Warsaw, Warsaw, Poland.
  • Kasperczyk S; Polish Society for Laboratory Diagnostics.
  • Broncel M; Department of Clinical Chemistry and Laboratory Diagnostics, Medical University of Warsaw, Warsaw, Poland.
  • Wolska A; Polish Lipid Association.
  • Odrowaz-Sypniewska G; Department of Family Medicine and Public Health, Faculty of Medicine, University of Opole, Opole, Poland.
  • Banach M; Polish Lipid Association.
Arch Med Sci ; 20(2): 357-374, 2024.
Article en En | MEDLINE | ID: mdl-38757022
ABSTRACT
Lipid disorders are the most common (even 70%) and worst monitored cardiovascular risk factor (only 1/4 of patients in Poland and in CEE countries are on the low-density lipoprotein cholesterol (LDL-C) goal). To improve this, clear and simple diagnostic criteria should be introduced for all components of the lipid profile. These are the updated guidelines of the two main scientific societies in Poland in the area - the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA), which, in comparison to those from 2020, introduce few important changes in recommendations (two main lipid targets, new recommendations on LDL-C measurements, calculations new goals for triglycerides, new recommendations on remnants and small dense LDL) that should help the practitioners to be early with the diagnosis of lipid disorders and in the effective monitoring (after therapy initiation), and in the consequence to avoid the first and recurrent cardiovascular events.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Arch Med Sci Año: 2024 Tipo del documento: Article Pais de publicación: Polonia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Arch Med Sci Año: 2024 Tipo del documento: Article Pais de publicación: Polonia